💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

Salesforce stock price target raised on modest growth rebound

EditorNatashya Angelica
Published 29/08/2024, 13:32
© Reuters
CRM
-

On Thursday, Loop Capital adjusted its price target for Salesforce.com (NYSE:CRM) shares , increasing it to $270 from the previous $240, while maintaining a Hold rating on the stock.

The decision follows Salesforce's reported improvement in its current Remaining Performance Obligations (cRPO) growth, which measures the future revenue under contract that has not yet been recognized. The growth rate hit 11% year-over-year in constant currency terms, surpassing both the firm's and the Street's expectations of 9% and 10%, respectively.

Despite a lackluster first quarter in bookings, Salesforce has seen a modest rebound in cRPO growth. This uptick has been partly attributed to early renewals, which have acted as a tailwind. Nonetheless, the company's management has signaled a continued cautious purchasing environment and has offered a conservative cRPO growth forecast of 9% year-over-year for the third quarter.

Salesforce's Data Cloud business, a critical component of its GenAI solutions, has been performing strongly, yet the company's overall growth remains around 10%. To boost its growth prospects, Salesforce has announced the Agentforce platform, which is set to be fully introduced at the upcoming Dreamforce event. Agentforce is notable for its consumption-based pricing model, which charges per conversation or transaction.

The adoption of Salesforce's GenAI products, including its Copilot offerings, is expected to be gradual due to their significant pricing premium, which ranges from $60 to $120 per user per month. The new consumption pricing model for GenAI agents is anticipated to facilitate faster adoption within Salesforce's existing customer base by reducing the need for a substantial initial investment.

While Salesforce's GenAI products and Data Cloud are key to achieving double-digit growth, Loop Capital will continue to monitor the company's progress in these areas. The firm's increased price target to $270 reflects slightly higher cash flow estimates, yet it awaits more definitive signs of acceleration in business trends driven by GenAI deals before altering its Hold rating.

In other recent news, Salesforce.com has seen several financial firms adjust their price targets following robust second fiscal quarter results. Oppenheimer raised the price target for Salesforce to $300, noting the company's record operating margin and an upward revision of its fiscal year 2025 operating margin and cash flow projections.

Similarly, Baird increased its price target to $315, pointing out the company's revenue and profitability surpassing expectations. Wells Fargo (NYSE:WFC) also adjusted its outlook, raising the price target to $275, acknowledging the company's resilience in core segments and the improvement in operating margins.

Moreover, Salesforce announced a change in their Chief Financial Officer (CFO) position, a development that might influence future revenue growth and business efficiency. Analysts from Edward Jones, Goldman Sachs (NYSE:GS), and Stifel maintained a positive outlook on Salesforce, with Goldman Sachs and Stifel raising their price targets to $325 and $320 respectively.

Salesforce's commitment to artificial intelligence (AI) has been a key factor in recent developments, with the company signing 1,500 AI deals in the second fiscal quarter. This strategic focus on AI is reflected in the year-over-year paid customer growth of more than 130% in its Data Cloud segment.

The company's growth strategy for fiscal 2025 projects a revenue range of $37.7 billion to $38 billion, with an anticipated 8-9% year-over-year growth and a non-GAAP operating margin improvement of 230 basis points. This projection is supported by firms such as Edward Jones, which highlighted Salesforce's potential for above-average growth due to the expanding digital capabilities of companies across various sectors.

InvestingPro Insights

As Salesforce.com (NYSE:CRM) continues to navigate the competitive landscape of the Software industry, the company's financial health and market performance offer valuable insights. With an impressive gross profit margin of 76.0% in the last twelve months as of Q1 2023, Salesforce demonstrates its ability to maintain profitability amidst industry challenges. This is further underscored by the company's perfect Piotroski Score of 9, indicating strong financial positioning.

Investors should note Salesforce's high earnings multiple, with a P/E ratio of 45.97, suggesting a premium market valuation. However, this is coupled with a substantial market capitalization of $250.87 billion, reflecting the company's prominence as a leading player in its sector. For those seeking additional analysis, InvestingPro offers further tips, including Salesforce's ability to sufficiently cover interest payments and its moderate level of debt, which contribute to its financial stability.

For a more comprehensive understanding of Salesforce's potential and to access a full suite of InvestingPro Tips, interested parties can explore the product that includes additional tips, with a total of 11 tips available for Salesforce.com.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.